Haduvio - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Anthropic is reportedly considering another advanced Claude model as competition with OpenAI intensifies across enterprise artificial-intelligence workloads. Representative image.

Anthropic weighs another Claude model as OpenAI Astra intensifies enterprise AI race

Arista Networks is expanding its EOS-based networking platform across 1.6-terabit Ethernet AI fabrics, hyperscale data centers, CloudVision and enterprise connectivity as artificial intelligence reshapes network architecture. Representative image.

Arista Networks company profile: How EOS and Ethernet are powering its AI data center expansion

Eli Lilly’s retatrutide moves closer to a planned 2027 U.S. filing after completing its core Phase 3 programme for obesity, knee pain and sleep apnea. Representative image.

Retatrutide development: Phase 3 results, 2027 FDA filing, TRIUMPH trials and what comes next

India and Canada are accelerating CEPA negotiations as LNG, nuclear energy and critical minerals become central to their expanding economic relationship. Representative image.

Canada targets India trade deal by year-end as LNG, nuclear and critical minerals talks deepen

Read More

Pharma Industry News

Trevi Therapeutics (NASDAQ: TRVI) bets everything on two Phase 3 chronic cough trials

Trevi Therapeutics (NASDAQ: TRVI) has no revenue and is up 71%, yet its future rides on two Phase 3 cough trials that do not read out until 2027.

June 7, 2026

Read More

Pharma Industry News

Trevi Therapeutics announces positive results for Haduvio in Phase 2b CORAL study

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, has reported a positive outcome from the planned sample size re-estimation…

byPallavi Madhiraju

December 12, 2024

web analytics